Global Clomiphene Citrate Market to Surpass US$ 14.51 Million by 2027, Says Coherent Market Insights

SEATTLE–(BUSINESS WIRE)–#ClomipheneCitrate–According to Coherent Market Insights, the global clomiphene citrate market is estimated to be valued at US$ 10.02 million in 2020 and is expected to exhibit a CAGR of 5.4% during the forecast period (2020-2027).

Key Trends and Analysis of the Global Clomiphene Citrate Market:

The increasing government initiatives to treat infertility is expected to drive growth of the clomiphene citrate market over the forecast period. For instance, in December 2015, the Ontario (Canada) government launched the Ontario Fertility Program, which provides funding to help individuals with infertility. The Ontario Fertility Program gives access to funded fertility services is available for all forms of infertility (including medical and non-medical infertility), regardless of gender, sexual orientation or family status.

Furthermore, key players are focused on creating awareness about infertility and increasing their customer base. For instance, in January 2016, Cipla Ltd. started educating people by spreading awareness from their company’s official website regarding the factors that are responsible for infertility in men and women.

Major players operating in the market are engaged in adopting inorganic growth strategies such as mergers and acquisitions to increase their global presence. For instance, in 2019, Avet Pharma Labs Inc., a subsidiary of Emcure Pharmaceuticals, acquired a portfolio of 23 abbreviated new drug applications (ANDAs), covering 17 product families, in order to launch them in the U.S. market. All the products have been previously approved by the U.S. (Read more…) Food and Drug Administration (FDA) and had been manufactured under a supply agreement with a third party.

Request Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4140

Key Market Takeaways:

The global clomiphene citrate market is expected to exhibit a CAGR of 5.4% during the forecast period (2020-2027), owing to increasing prevalence of PCOS in women. For instance, according to article published in 2014 in Clinical Epidemiology, polycystic ovarian syndrome affects 8% to 20% of the reproductive-age women, globally. According to the World Health Organization, in 2012, polycystic ovarian syndrome affected 116 million women, worldwide.

Asia Pacific clomiphene citrate market is expected to increase over the forecast period, owing to the rising prevalence of infertility in the region. Economies such as China, Japan, Malaysia, and others are expected to be potential markets for clomiphene due to high prevalence of infertility in couples in these countries. For instance, according to a report ‘Fertility trends in Asia: A Snapshot’ published in Merck’s Website in May 2019, couples in Asia Pacific region are marrying late and the birth rates are declining due to the rising age of the couples. Most countries in the region are already below the birth rate of 2.1 to 1.3 children per woman.

Competitive Landscape:

Key players operating in the global clomiphene citrate market include Sanofi S.A., Par Pharmaceutical, Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., Cipla Inc., Unichem Laboratories Ltd., Emcure Pharmaceuticals Ltd., Serum Institute of India Pvt. Ltd., Incepta Pharmaceuticals Ltd., and Shanghai Trifecta Pharma Co. Ltd.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4140

Market Segmentation:

• Global Clomiphene Citrate Market, By Indication:
  • PCOS
  • Secondary Amenorrhea
  • Psychogenic Amenorrhea
  • Amenorrhea Galactorrhea Syndrome
  • Others
• Global Clomiphene Citrate Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Global Clomiphene Citrate Market, By Region:
  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Australia
    • India
    • China
    • Japan
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Central Africa
    • North Africa

Related Market Intelligence Report:

Anhydrous Dibasic Calcium Phosphate Market, by Source (Hydrochloric Acid and Phosphoric Acid), by End-Use (Animal Feed, Food & Beverage, Agriculture, Pharmaceutical, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027

Read more: https://www.coherentmarketinsights.com/market-insight/anhydrous-dibasic-calcium-phosphate-market-4053

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.

Contacts

Mr. Shah

Senior Client Partner – Business Development

Coherent Market Insights

Phone:
US: +1-206-701-6702

UK: +44-020-8133-4027

Japan: +81-050-5539-1737

India: +91-848-285-0837

Email: [email protected]
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter